Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

The effects of flavonoids on human first trimester trophoblast spheroidal stem cell self-renewal, invasion and JNK/p38 MAPK activation: Understanding the cytoprotective effects of these phytonutrients against oxidative stress.

Ebegboni VJ, Balahmar RM, Dickenson JM, Sivasubramaniam SD.

Biochem Pharmacol. 2019 Jun;164:289-298. doi: 10.1016/j.bcp.2019.04.023. Epub 2019 Apr 22.

PMID:
31022396
2.

Antioxidative effects of flavonoids and their metabolites against hypoxia/reoxygenation-induced oxidative stress in a human first trimester trophoblast cell line.

Ebegboni VJ, Dickenson JM, Sivasubramaniam SD.

Food Chem. 2019 Jan 30;272:117-125. doi: 10.1016/j.foodchem.2018.08.036. Epub 2018 Aug 9.

PMID:
30309520
3.

Improving the quality of cognitive screening assessments: ACEmobile, an iPad-based version of the Addenbrooke's Cognitive Examination-III.

Newman CGJ, Bevins AD, Zajicek JP, Hodges JR, Vuillermoz E, Dickenson JM, Kelly DS, Brown S, Noad RF.

Alzheimers Dement (Amst). 2017 Dec 29;10:182-187. doi: 10.1016/j.dadm.2017.12.003. eCollection 2018.

4.

Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.

Algarni AS, Hargreaves AJ, Dickenson JM.

Eur J Pharmacol. 2018 Feb 5;820:113-129. doi: 10.1016/j.ejphar.2017.12.023. Epub 2017 Dec 11.

PMID:
29242118
5.

Role of transglutaminase 2 in A1 adenosine receptor- and β2-adrenoceptor-mediated pharmacological pre- and post-conditioning against hypoxia-reoxygenation-induced cell death in H9c2 cells.

Vyas FS, Nelson CP, Dickenson JM.

Eur J Pharmacol. 2018 Jan 15;819:144-160. doi: 10.1016/j.ejphar.2017.11.049. Epub 2017 Dec 5.

PMID:
29208472
6.

β2-adrenoceptor-induced modulation of transglutaminase 2 transamidase activity in cardiomyoblasts.

Vyas FS, Nelson CP, Freeman F, Boocock DJ, Hargreaves AJ, Dickenson JM.

Eur J Pharmacol. 2017 Oct 15;813:105-121. doi: 10.1016/j.ejphar.2017.07.043. Epub 2017 Jul 25.

PMID:
28754379
7.

Role of transglutaminase 2 in PAC1 receptor mediated protection against hypoxia-induced cell death and neurite outgrowth in differentiating N2a neuroblastoma cells.

Algarni AS, Hargreaves AJ, Dickenson JM.

Biochem Pharmacol. 2017 Mar 15;128:55-73. doi: 10.1016/j.bcp.2017.01.001. Epub 2017 Jan 5.

PMID:
28065858
8.

A1 adenosine receptor-induced phosphorylation and modulation of transglutaminase 2 activity in H9c2 cells: A role in cell survival.

Vyas FS, Hargreaves AJ, Bonner PL, Boocock DJ, Coveney C, Dickenson JM.

Biochem Pharmacol. 2016 May 1;107:41-58. doi: 10.1016/j.bcp.2016.03.016. Epub 2016 Mar 21.

PMID:
27005940
9.

Phenyl Saligenin Phosphate Induced Caspase-3 and c-Jun N-Terminal Kinase Activation in Cardiomyocyte-Like Cells.

Felemban SG, Garner AC, Smida FA, Boocock DJ, Hargreaves AJ, Dickenson JM.

Chem Res Toxicol. 2015 Nov 16;28(11):2179-91. doi: 10.1021/acs.chemrestox.5b00338. Epub 2015 Oct 23.

PMID:
26465378
10.

Cardioprotective and cardiotoxic effects of quercetin and two of its in vivo metabolites on differentiated h9c2 cardiomyocytes.

Daubney J, Bonner PL, Hargreaves AJ, Dickenson JM.

Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):96-109. doi: 10.1111/bcpt.12319. Epub 2014 Oct 13.

11.

Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.

Almami I, Dickenson JM, Hargreaves AJ, Bonner PL.

Br J Pharmacol. 2014 Aug;171(16):3946-60. doi: 10.1111/bph.12756.

12.

Processing of fluorescence lifetime image using modified phasor approach: homo-FRET from the acceptor.

Zhou Y, Bai Y, Chen C, Dickenson JM.

J Fluoresc. 2013 Jul;23(4):725-32. doi: 10.1007/s10895-013-1193-y. Epub 2013 Mar 15.

PMID:
23494166
13.

The MPTP status during early reoxygenation is critical for cardioprotection.

Husainy MA, Dickenson JM, Galiñanes M.

J Surg Res. 2012 May 1;174(1):62-72. doi: 10.1016/j.jss.2010.11.879. Epub 2010 Dec 9.

PMID:
21316705
14.

Role of large-conductance Ca²+-activated K+ channels in adenosine A₁ receptor-mediated pharmacological postconditioning in H9c2 cells.

Fretwell L, Dickenson JM.

Can J Physiol Pharmacol. 2011 Jan;89(1):24-30. doi: 10.1139/y10-106.

PMID:
21186374
15.

Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury.

Linares-Palomino J, Husainy MA, Lai VK, Dickenson JM, Galiñanes M.

J Physiol. 2010 Jun 15;588(Pt 12):2173-91. doi: 10.1113/jphysiol.2010.190462. Epub 2010 Apr 19.

16.

Role of large-conductance Ca(2+) -activated potassium channels in adenosine A(1) receptor-mediated pharmacological preconditioning in H9c2 cells.

Fretwell L, Dickenson JM.

Eur J Pharmacol. 2009 Sep 15;618(1-3):37-44. doi: 10.1016/j.ejphar.2009.07.008. Epub 2009 Jul 18.

PMID:
19619521
17.

Characterization of P2Y receptor subtypes functionally expressed on neonatal rat cardiac myofibroblasts.

Talasila A, Germack R, Dickenson JM.

Br J Pharmacol. 2009 Sep;158(1):339-53. doi: 10.1111/j.1476-5381.2009.00172.x. Epub 2009 May 5.

18.

Imaging lifetime and anisotropy spectra in the frequency domain.

Zhou Y, Dickenson JM, Hanley QS.

J Microsc. 2009 Apr;234(1):80-8. doi: 10.1111/j.1365-2818.2009.03145.x.

19.

Functional expression of the P2Y14 receptor in human neutrophils.

Scrivens M, Dickenson JM.

Eur J Pharmacol. 2006 Aug 14;543(1-3):166-73. Epub 2006 Jun 7.

PMID:
16820147
20.
21.
22.

Functional expression of the P2Y14 receptor in murine T-lymphocytes.

Scrivens M, Dickenson JM.

Br J Pharmacol. 2005 Oct;146(3):435-44.

23.

Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.

Button L, Mireylees SE, Germack R, Dickenson JM.

Exp Physiol. 2005 Sep;90(5):747-54. Epub 2005 Jun 17.

24.

Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression.

Scrivens M, Dickenson JM.

Pharmacol Res. 2005 Jun;51(6):533-8.

PMID:
15829433
25.

Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes.

Germack R, Griffin M, Dickenson JM.

J Mol Cell Cardiol. 2004 Nov;37(5):989-99.

PMID:
15522276
26.
27.
28.

Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106.

Dickenson JM, Reeder S, Rees B, Alexander S, Kendall D.

Eur J Pharmacol. 2003 Aug 1;474(1):43-51.

PMID:
12909194
30.
32.

Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A3 receptor in transfected CHO cells.

Graham S, Combes P, Crumiere M, Klotz KN, Dickenson JM.

Eur J Pharmacol. 2001 May 18;420(1):19-26.

PMID:
11412835
33.

Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.

Robinson AJ, Dickenson JM.

Eur J Pharmacol. 2001 Feb 16;413(2-3):151-61.

PMID:
11226388
35.

Activation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cells.

Germack R, Dickenson JM.

Br J Pharmacol. 2000 Jun;130(4):867-74.

37.
39.
40.
42.
44.
45.
46.

Spectroscopic characterisation of disaccharides derived from keratan sulfates.

Huckerby TN, Brown GM, Dickenson JM, Nieduszynski IA.

Eur J Biochem. 1995 Apr 1;229(1):119-31.

47.

Activation of phospholipase C by G-protein beta gamma subunits in DDT1MF-2 cells.

Dickenson JM, Camps M, Gierschik P, Hill SJ.

Eur J Pharmacol. 1995 Feb 15;288(3):393-8.

PMID:
7774686
48.

Activation of phospholipase C by G-protein beta gamma subunits in DDT1MF-2 cells.

Dickenson JM, Hill SJ.

Biochem Soc Trans. 1995 Feb;23(1):17S. No abstract available.

PMID:
7758722
49.

Measurement of intracellular free calcium ion concentration in cell populations using fura-2.

Iredale PA, Dickenson JM.

Methods Mol Biol. 1995;41:203-13. No abstract available.

PMID:
7655557
50.

Supplemental Content

Loading ...
Support Center